Hot Springs Buprenorphine Doctors


Feature Your Practice at the Top of This City Page

Locate Hot Springs buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.

Dr. Sharron Marie Mason, M.D.
Mason Medical Clinic
113 Lakeshore Drive
Hot Springs, AR 71913
Main Tel: (501) 463-9079
 
 
Dr. Steven James Halter, M.D.
615 West Grand Avenue
Hot Springs, AR 71901
Main Tel: (501) 617-6984
 
 
Dr. Thomas Franklin Robinson, M.D.
Stockton Medical Group of Hot Springs
1 Mercy Lane, Suite 403
Hot Springs, AR 71913
Main Tel: (501) 319-7963
 
 
Dr. Eugene M. Shelby, M.D.
137 Circle Drive
Hot Springs, AR 71901
Main Tel: (501) 623-2606
 
 
Dr. Sharron Marie Mason, M.D.
113 Lakeshore Drive
Hot Springs, AR 71913
Main Tel: (501) 463-9079
 
 
Dr. Gary Norton Meek, M.D.
812 Mountain Pine Road
Hot Springs, AR 71913
Main Tel: (501) 767-4456
 
 
Dr. Michael Watson Verser, M.D.
812 Mount Pine Road
Hot Springs, AR 71913
Main Tel: (501) 767-4456
 
 
Dr. William Leonard Mizell, D.O.
Quapaw House Inc.
812 Mountain Pine Road
Hot Springs, AR 71913
Main Tel: (501) 767-4583
 
 
John Scott Erwin, M.D.
Hamilton West Family Medicine
1629 Airport Road, SuiteB
Hot Springs, AR 71913
Main Tel: (501) 767-6605
 
 
Kevin Hale, M.D.
1629 Airport Road
Hot Springs, AR 71913
Main Tel: (501) 767-0051
 
 

Sublocade Now Available

Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More

Posted in Buprenorphine, Medication-Assisted Treatment | Tagged | Leave a comment

Ohio Increases Buprenorphine Access

In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More

Posted in Addiction Medications, Buprenorphine, Medication-Assisted Treatment, Suboxone | Tagged , | Leave a comment

The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.

Buprenorphine is the medication ingredient in Suboxone, Subutex, Zubsolv, Bunavail, and Probuphine that specifically targets opioid withdrawal. Buprenorphine, or "Bup", is the leading pharmaceutical treatment (alongside methadone) for addressing opioid addiction. Both medications are in widescale use throughout the world due to their efficacy in removing the persistent discomfort associated with withdrawal from opiates (ex. runny nose, body ache, anxiety, nausea, diarrhea and other symptoms).

Buprenorphine.US is an information resource for people in search of doctors who specialize in treating opioid addiction with buprenorphine. In recent years, individuals from all age groups and backgrounds have suffered with an unexpected opioid dependency that negatively affected their family relationships, job, finances, and self-esteem. Addiction is a relentless illness, and persistent opiate withdrawal is a particularly difficult medical dilemma. There are presently thousands of U.S. physicians seeking to assist patients ready to address their opioid addiction. Buprenorphine.US is a tool for connecting buprenorphine doctors with new prospective patients wanting specialized primary care for their addictive disorder.